Literature DB >> 8514384

Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides.

P Salo1, A Närvänen, M Leinonen.   

Abstract

In the search for better diagnostic tools and improved vaccines against pneumococcal diseases, continuous antigenic sites of the pneumococcal pneumolysin molecule were identified with partially overlapping synthetic peptides. Peptides were derived from the predicted amino acid sequence according to the known DNA sequence of pneumolysin. The immunoreactivities of the peptides were studied by enzyme immunoassay with seven human serum samples and three rabbit hyperimmune serum samples. Two immunoreactive sites in the overlapping peptides at the amino-terminal end of the pneumolysin molecule were identified in this study. Two common immunoreactive sites for both human and rabbit sera were demonstrated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514384      PMCID: PMC280926          DOI: 10.1128/iai.61.7.2822-2826.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

2.  Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.

Authors:  J C Paton; A Ferrante
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

3.  Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae.

Authors:  J C Paton; R A Lock; D J Hansman
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

4.  Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis.

Authors:  S Taira; E Jalonen; J C Paton; M Sarvas; K Runeberg-Nyman
Journal:  Gene       Date:  1989-04-30       Impact factor: 3.688

5.  Cloning and expression in Escherichia coli of the Streptococcus pneumoniae gene encoding pneumolysin.

Authors:  J C Paton; A M Berry; R A Lock; D Hansman; P A Manning
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

6.  Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.

Authors:  A Ferrante; B Rowan-Kelly; J C Paton
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.

Authors:  T J Mitchell; P W Andrew; F K Saunders; A N Smith; G J Boulnois
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

8.  Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin).

Authors:  M Kalin; K Kanclerski; M Granström; R Möllby
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

9.  The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods.

Authors:  Y Kerttula; M Leinonen; M Koskela; P H Mäkelä
Journal:  J Infect       Date:  1987-01       Impact factor: 6.072

10.  Secretion of Escherichia coli beta-lactamase from Bacillus subtilis by the aid of alpha-amylase signal sequence.

Authors:  I Palva; M Sarvas; P Lehtovaara; M Sibakov; L Kääriäinen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more
  6 in total

1.  Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.

Authors:  Lea-Ann S Kirkham; Alison R Kerr; Gill R Douce; Gavin K Paterson; Deborah A Dilts; Dai-Fang Liu; Tim J Mitchell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Crucial role of perfringolysin O D1 domain in orchestrating structural transitions leading to membrane-perforating pores: a hydrogen-deuterium exchange study.

Authors:  Aleksandra Kacprzyk-Stokowiec; Magdalena Kulma; Gabriela Traczyk; Katarzyna Kwiatkowska; Andrzej Sobota; Michał Dadlez
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

3.  Functional analysis of pneumolysin by use of monoclonal antibodies.

Authors:  J R de los Toyos; F J Méndez; J F Aparicio; F Vázquez; M Del Mar García Suárez; A Fleites; C Hardisson; P J Morgan; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

4.  Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Authors:  J K Pullen; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Molecular cloning, sequencing, expression, and characterization of an immunogenic 43-kilodalton lipoprotein of Bartonella bacilliformis that has homology to NlpD/LppB.

Authors:  I Padmalayam; T Kelly; B Baumstark; R Massung
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.

Authors:  A Virolainen; J Jero; H Käyhty; P Karma; J Eskola; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.